Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mackie

Showing results (251-260 of 366) with videos related to

Pageof 37
Sort By:
Journal of Thrombosis and Haemostasis : JTH|April 9, 2015
Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndromeD R J Arachchillage, I J Mackie, M Efthymiou, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1990
Heparin cofactor II levels are increased by the use of combined oral contraceptivesI J Mackie, H Segal, T Burren, et al.
Lancet (London, England)|May 30, 2001
Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trialJ H Scurr, S J Machin, S Bailey-King, et al.
British Journal of Haematology|July 10, 2001
Protein S levels are lower in women receiving desogestrel-containing combined oral contraceptives (COCs) than in women receiving levonorgestrel-containing COCs at steady state and on cross-overI J Mackie, K Piegsa, S A Furs, et al.
Journal of Medical Entomology|July 1, 1994
Isotopes as host blood markers to measure blood intake by feeding ticks (Acari: Ixodidae)Y Rechav, W J Strydom, F C Clarke, et al.
British Journal of Haematology|March 18, 2008
The VWF/ADAMTS13 axis in the antiphospholipid syndrome: ADAMTS13 antibodies and ADAMTS13 dysfunctionS K Austin, R D Starke, A S Lawrie, et al.
Thrombosis Research|January 4, 2015
Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolismD R J Arachchillage, M Efthymiou, I J Mackie, et al.
The Prostate|February 15, 2022
Protease-activated receptor-2 dependent and independent responses of bone cells to prostate cancer cell secretory productsCharles N Pagel, Pamu K Kularathna, Reza Sanaei, et al.
The British Journal of Dermatology|January 1, 1991
Tenascin expression in hyperproliferative skin diseasesJ Schalkwijk, I Van Vlijmen, B Oosterling, et al.
The New Zealand Medical Journal|December 8, 1995
Fletcher Challenge-University of Auckland Heart & Health Study: design and baseline findingsS MacMahon, R Norton, R Jackson, et al.
Pageof 37

Showing results (251-260 of 366) with videos related to

Sort By:
Pageof 37
Journal of Thrombosis and Haemostasis : JTH|April 9, 2015
Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndromeD R J Arachchillage, I J Mackie, M Efthymiou, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1990
Heparin cofactor II levels are increased by the use of combined oral contraceptivesI J Mackie, H Segal, T Burren, et al.
Lancet (London, England)|May 30, 2001
Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trialJ H Scurr, S J Machin, S Bailey-King, et al.
British Journal of Haematology|July 10, 2001
Protein S levels are lower in women receiving desogestrel-containing combined oral contraceptives (COCs) than in women receiving levonorgestrel-containing COCs at steady state and on cross-overI J Mackie, K Piegsa, S A Furs, et al.
Journal of Medical Entomology|July 1, 1994
Isotopes as host blood markers to measure blood intake by feeding ticks (Acari: Ixodidae)Y Rechav, W J Strydom, F C Clarke, et al.
British Journal of Haematology|March 18, 2008
The VWF/ADAMTS13 axis in the antiphospholipid syndrome: ADAMTS13 antibodies and ADAMTS13 dysfunctionS K Austin, R D Starke, A S Lawrie, et al.
Thrombosis Research|January 4, 2015
Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolismD R J Arachchillage, M Efthymiou, I J Mackie, et al.
The Prostate|February 15, 2022
Protease-activated receptor-2 dependent and independent responses of bone cells to prostate cancer cell secretory productsCharles N Pagel, Pamu K Kularathna, Reza Sanaei, et al.
The British Journal of Dermatology|January 1, 1991
Tenascin expression in hyperproliferative skin diseasesJ Schalkwijk, I Van Vlijmen, B Oosterling, et al.
The New Zealand Medical Journal|December 8, 1995
Fletcher Challenge-University of Auckland Heart & Health Study: design and baseline findingsS MacMahon, R Norton, R Jackson, et al.
Pageof 37